Related Experiment Videos
An appraisal of cardiovascular standards for Australian civilian flying licences
1Aviation Medicine Branch, Civil Aviation Authority, Canberra.
Insights
Cardiologists and aviation experts updated cardiovascular standards for pilot licenses. Ischemic heart disease remains a key disqualifier, prompting recommendations for risk factor assessment and supervised licensing for select cases.
Area of Science:
- Cardiology
- Aviation Medicine
- Aerospace Medicine
Background:
- Cardiovascular conditions are a primary reason for disqualification from civil flying licenses.
- Existing cardiovascular standards require review to ensure pilot fitness and safety.
Purpose of the Study:
- To review and update cardiovascular standards for Australian Civil Flying Licences.
- To address disqualifications related to ischemic heart disease and other cardiac conditions.
Main Methods:
- Convened a panel of Cardiologists and Aviation Medical personnel.
- Reviewed existing data and clinical guidelines for cardiovascular standards.
- Developed recommendations for various cardiac conditions.
Main Results:
- Ischemic heart disease identified as the most common cause of disqualification.
- Recommendations include assessing coronary risk factors and focusing on high-risk individuals.
- Guidelines established for licensing individuals with valvular heart disease, arrhythmias, pacemakers, cardiomyopathy, and hypertension.
Conclusions:
- Supervised licensing may be permissible for carefully selected pilots with ischemic heart disease.
- Updated guidelines aim to balance aviation safety with the needs of pilots with cardiac conditions.
Abstract:
This paper summarises recommendations drawn up at a meeting of a group of Cardiologists and Aviation Medical personnel to review cardiovascular standards for Australian Civil Flying Licences. Major recommendations were in the field of ischemic heart disease which remains the commonest cause of disqualification. The panel recommended consideration of coronary risk factors and increased attention to the high risk group as a preventive measure for loss of licence. Licensing, with appropriate safeguards and continued supervision, was considered permissible in carefully selected subjects with ischemic heart disease. Guidelines were also drawn up for various licence categories for subjects with valvular heart disease, cardiac arrhythmias, implanted pacemakers, cardiomyopathy and hypertension.